Glioma Clinical Trials in Rochester, Minnesota
13 recruitingRochester, Minnesota
Showing 1–13 of 13 trials
Recruiting
Phase 1Phase 2
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
ParagangliomaPheochromocytomaMeningioma+4 more
Perspective Therapeutics300 enrolled19 locationsNCT05636618
Recruiting
Not Applicable
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
GliomaPilocytic AstrocytomaPleomorphic Xanthoastrocytoma+2 more
St. Jude Children's Research Hospital74 enrolled2 locationsNCT04065776
Recruiting
Phase 3
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
GliomaH3 K27M
Jazz Pharmaceuticals510 enrolled162 locationsNCT05580562
Recruiting
Not Applicable
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma
GliomaRecurrent Glioma
Mayo Clinic120 enrolled2 locationsNCT07074756
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
GliomaAstrocytoma, IDH-Mutant, Grade 2Astrocytoma, Grade IV+5 more
Nuvation Bio Inc.365 enrolled45 locationsNCT05303519
Recruiting
Phase 2
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Advanced Pheochromocytoma and ParagangliomaPCPG
Jazz Pharmaceuticals90 enrolled9 locationsNCT07282587
Recruiting
Not Applicable
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Metastatic Malignant Neoplasm in the BrainGlioblastomaGlioma
Mayo Clinic100 enrolled1 locationNCT04047264
Recruiting
Early Phase 1
Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease
Glioma
Mayo Clinic10 enrolled1 locationNCT07025226
Recruiting
Phase 2
Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study
Diffuse Midline Glioma, H3 K27M-Mutant
Mayo Clinic29 enrolled2 locationsNCT05077735
Recruiting
Phase 2
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma
WHO Grade 4 GliomaWHO Grade 3 Glioma
Mayo Clinic25 enrolled1 locationNCT06444412
Recruiting
Early Phase 1
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Diffuse GliomaMalignant Glioma
Mayo Clinic18 enrolled1 locationNCT05717153
Recruiting
Phase 1Phase 2
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
GliomaGlioblastoma Multiforme
Aveta Biomics, Inc.30 enrolled2 locationsNCT06011109
Recruiting
Phase 2
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Recurrent GlioblastomaRecurrent WHO Grade 4 Glioma
Academic and Community Cancer Research United134 enrolled3 locationsNCT06160206